PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema

NAActive, not recruitingINTERVENTIONAL

Enrollment

260

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

November 17, 2026

Study Completion Date

November 17, 2026

Conditions

Lymphedema

Interventions

OTHER

Cohort I (patients receiving annual lymphedema screening

patientns who previously underwent preoperative perometer lymphedema screening

OTHER

Cohort II (patients followed intensively for lymphedema)

patients who have recently undergone ALND

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER

NCT05056207 - PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema | Biotech Hunter | Biotech Hunter